Evaluation of the efficacy of a pre-pandemic H5N1 vaccine (MG1109) in mouse and ferret models.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 22752912)

Published in J Microbiol on June 30, 2012

Authors

Min-Suk Song1, Ho-Jin Moon, Hyeok-Il Kwon, Philippe Noriel Q Pascua, Jun Han Lee, Yun Hee Baek, Gyu-Jin Woo, Kyu-Jin Woo, Juhee Choi, Sangho Lee, Hyunseung Yoo, Ingyeong Oh, Yeup Yoon, Jong-Bok Rho, Moon-Hee Sung, Seung-Pyo Hong, Chul-Joong Kim, Young Ki Choi

Author Affiliations

1: College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, 361-763, Republic of Korea.

Articles by these authors

Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab (2005) 7.15

Ubiquitin-binding domains. Biochem J (2006) 5.32

Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro. J Biol Chem (2006) 2.69

Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer. Cell (2007) 2.21

Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies. Clin Cancer Res (2013) 2.07

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe (2013) 1.86

The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model. J Virol (2009) 1.68

Evidence of human-to-swine transmission of the pandemic (H1N1) 2009 influenza virus in South Korea. J Clin Microbiol (2010) 1.64

Structural and functional organization of the ESCRT-I trafficking complex. Cell (2006) 1.51

Highly pathogenic avian influenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea. Emerg Infect Dis (2008) 1.48

Continuing evolution of H9 influenza viruses in Korean poultry. Virology (2006) 1.45

Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection. PLoS One (2009) 1.42

Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea. J Virol (2009) 1.40

Production of omega-3 eicosapentaenoic acid by metabolic engineering of Yarrowia lipolytica. Nat Biotechnol (2013) 1.38

Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer (2006) 1.30

Pak1 protein kinase regulates activation and nuclear localization of Snf1-Gal83 protein kinase. Mol Cell Biol (2004) 1.30

Display of alpha-amylase on the surface of Lactobacillus casei cells by use of the PgsA anchor protein, and production of lactic acid from starch. Appl Environ Microbiol (2006) 1.27

Autophagy protein Rubicon mediates phagocytic NADPH oxidase activation in response to microbial infection or TLR stimulation. Cell Host Microbe (2012) 1.16

The GPRLQPY motif located at the carboxy-terminal of the spike protein induces antibodies that neutralize Porcine epidemic diarrhea virus. Virus Res (2007) 1.16

Structural mechanism for ubiquitinated-cargo recognition by the Golgi-localized, gamma-ear-containing, ADP-ribosylation-factor-binding proteins. Proc Natl Acad Sci U S A (2005) 1.16

Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses. J Virol (2011) 1.13

Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications. Chem Rec (2005) 1.12

Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol (2006) 1.12

Seroprevalence and genetic evolutions of swine influenza viruses under vaccination pressure in Korean swine herds. Virus Res (2008) 1.12

Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway. FASEB J (2002) 1.11

Gold nanoparticles surface-functionalized with paclitaxel drug and biotin receptor as theranostic agents for cancer therapy. Biomaterials (2011) 1.10

alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem (2003) 1.09

Rapid evolution of low-pathogenic H9N2 avian influenza viruses following poultry vaccination programmes. J Gen Virol (2010) 1.08

Virulence and transmissibility of H1N2 influenza virus in ferrets imply the continuing threat of triple-reassortant swine viruses. Proc Natl Acad Sci U S A (2012) 1.08

Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza. PLoS One (2011) 1.08

Improved recombinant gene expression in CHO cells using matrix attachment regions. J Biotechnol (2004) 1.07

Serologic and genetic characterization of North American H3N2 swine influenza A viruses. Can J Vet Res (2007) 1.05

Integrative package for low back pain with leg pain in Korea: a prospective cohort study. Complement Ther Med (2010) 1.03

Near-infrared emitting polymer nanogels for efficient sentinel lymph node mapping. ACS Nano (2012) 1.02

Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). J Biol Chem (2003) 1.02

Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination. Clin Vaccine Immunol (2011) 1.02

The effect of immobilization of heparin and bone morphogenic protein-2 (BMP-2) to titanium surfaces on inflammation and osteoblast function. Biomaterials (2010) 1.01

Quantitative evaluation of cardiomyocyte contractility in a 3D microenvironment. J Biomech (2008) 1.01

Identification and characterization of new microRNAs from pig. Mamm Genome (2008) 1.00

Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine (2011) 0.99

Effect of GCSB-5, a Herbal Formulation, on Monosodium Iodoacetate-Induced Osteoarthritis in Rats. Evid Based Complement Alternat Med (2012) 0.99

Portable document format file showing the surface models of cadaver whole body. J Korean Med Sci (2012) 0.98

Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea. J Clin Microbiol (2006) 0.97

Active reassortment of H9 influenza viruses between wild birds and live-poultry markets in Korea. Arch Virol (2009) 0.97

Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax. Virol J (2011) 0.97

Std1p (Msn3p) positively regulates the Snf1 kinase in Saccharomyces cerevisiae. Genetics (2003) 0.96

Emergence of mammalian species-infectious and -pathogenic avian influenza H6N5 virus with no evidence of adaptation. J Virol (2011) 0.95

Role of Tos3, a Snf1 protein kinase kinase, during growth of Saccharomyces cerevisiae on nonfermentable carbon sources. Eukaryot Cell (2005) 0.95

A Case of a Pulmonary Arteriovenous Malformation With Ebstein's Anomaly. Korean Circ J (2010) 0.95

Effects of bone morphogenetic protein-7 (BMP-7) on primordial follicular growth in the mouse ovary. Mol Reprod Dev (2004) 0.95

Structure of the Bateman2 domain of yeast Snf4: dimeric association and relevance for AMP binding. Structure (2007) 0.94

Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling. Brain (2012) 0.94

Oral administration of human papillomavirus type 16 E7 displayed on Lactobacillus casei induces E7-specific antitumor effects in C57/BL6 mice. Int J Cancer (2006) 0.94

Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes. J Hepatol (2008) 0.94

Protective effect of GCSB-5, an herbal preparation, against peripheral nerve injury in rats. J Ethnopharmacol (2011) 0.94

Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine. Vaccine (2012) 0.94

Investigation of the biological indicator for vaccine efficacy against highly pathogenic avian influenza (HPAI) H5N1 virus challenge in mice and ferrets. Vaccine (2009) 0.93